Trial reportSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2026
Reduction of Ultraviolet- and Heat-Induced Aging Using Betulin-Loaded Arginine-Caprylate Self-Assembly: Randomized Double-Blind Clinical Trials.
Trial report in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBetulin exhibits potent antibacterial, anti-inflammatory, and antioxidant properties, effectively preventing ultraviolet (UV)- and heat-induced skin aging. Its limited solubility in cosmetic solvents restricts its application.
methodsTo enhance betulin's applicability, a self-assembled nanocarrier, arginine-caprylate ion pair loaded with betulin (B-ACS), was developed. Structural properties, loading efficiency, skin permeability, and antioxidant activity were assessed. UVB-induced damage was examined in human keratinocytes (HaCaT; n = 3) by measuring inflammatory cytokines and matrix metalloproteinases (MMPs) via ELISA. Three-dimensional reconstructed human skin models were exposed to UVA (10 J/cm
resultsB-ACS showed a particle size of 236.9 ± 10.3 nm, 98.3 ± 1.3 % encapsulation efficacy, and superior reactive oxygen species (ROS) scavenging (IC50 = 4.87 ppm) compared to free betulin (IC50 = 8.26 ppm). In HaCaT cells, B-ACS significantly reduced UVB-induced inflammatory cytokine and MMP expressions (p < 0.05). In reconstructed skin, it prevented UVA-induced collagen and aquaporin-3 degradation. Clinically, 3% B-ACS cream significantly improved elasticity (1.69-fold), brightness (2.59-fold), and pigmentation (1.91-fold); transepidermal water loss (TEWL) and heat-aging markers decreased 1.39-fold and 1.63-fold versus placebo, respectively (p < 0.05).
conclusionB-ACS enhances betulin's solubility and delivery, offering potent efficacy against UV- and heat-induced aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.